vanadyl sulfate has been researched along with Alloxan Diabetes in 57 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (3.51) | 18.7374 |
| 1990's | 24 (42.11) | 18.2507 |
| 2000's | 21 (36.84) | 29.6817 |
| 2010's | 9 (15.79) | 24.3611 |
| 2020's | 1 (1.75) | 2.80 |
| Authors | Studies |
|---|---|
| El-Kawi, SHA; Hashem, KS; Hozayen, W; Kamel, AKA | 1 |
| Ben Rhouma, K; Kamel, K; Mounira, T; Sakly, M; Samira, M; Tebourbi, O; Yacoubi, MT | 1 |
| Tunali, S; Yanardag, R | 3 |
| Akev, N; Can, A; Kurt-Sirin, O; Tunali, S; Yanardag, R; Yilmaz-Ozden, T | 1 |
| Ben Rhouma, K; Missaoui, S; Sakly, M; Tebourbi, O; Yacoubi, MT | 1 |
| Ahmed El-Shazly, S; Ahmed, MM; Ibrahim, ZS; Refat, MS | 1 |
| Hussain Shah, SZ; Naveed, AK; Rashid, A | 1 |
| El-Shazly, SA; Refat, MS | 1 |
| Ahmadi, S; Bahadori, M; Dehghani, GA; Karimian, SM; Sotoudeh, M | 1 |
| Akev, N; Can, A; Kurt, O; Ozden, TY; Ozsoy, N; Tunali, S; Yanardag, R | 1 |
| Bellman, KD; Bhanot, S; Cassidy, C; Karunaratne, V; Liboiron, BD; McNeill, JH; Orvig, C; Patrick, BO; Rawji, G; Setyawati, IA; Sun, Y; Sutton, K; Thompson, KH; Wheeler, J; Yuen, VG | 1 |
| Bolkent, S; Karabulut-Bulan, O; Tunali, S; Yanardag, R | 1 |
| Fugono, J; Sakurai, H; Yasui, H | 2 |
| Dabroś, W; Goc, A; Kordowiak, AM; Turyna, B | 1 |
| Bolkent, S; Koyuturk, M; Tunali, S; Yanardag, R | 1 |
| Najjar, TA; Saad, SY | 1 |
| Hiromura, M; Kataoka, S; Sakurai, H; Yasui, H | 1 |
| Balaraman, R; Giridhar, R; Majithiya, JB; Yadav, MR | 1 |
| Aikawa, J; Fernandes, LC; Hirabara, SM; Lissa, MD; Lopes, MC; Nogata, C; Nunes, EA; Tanhoffer, RA; Tchaikovski, OJ; Yamazaki, RK | 1 |
| Bolkent, S; Tunali, S; Yanardag, R | 1 |
| Chi, LH; Crans, DC; Gaile, DP; Hu, Z; Liang, Y; Willsky, GR | 1 |
| Barve, V; Bhonde, R; Padhye, S; Shukla, R | 1 |
| Ayvalik, SZ; Dirican, M; Sarandol, E; Serdar, Z; Tas, S | 1 |
| Fernández, MA; Filinger, EJ; Lemberg, A; Ouviña, G; Peredo, HA; Rodríguez, RR; Susemihl, C; Villarreal, I | 1 |
| Fujiwara, C; Kakegawa, H; Matsushita, R; Nakai, M; Sakurai, H; Satoh, T; Takada, J; Watanabe, H | 1 |
| Chen, X; Diamond, J; Hei, YJ; McNeill, JH; Pelech, SL | 1 |
| McNeill, JH; Orvig, C; Yuen, VG | 1 |
| Dai, S; McNeill, JH; Thompson, KH; Vera, E | 1 |
| Altan, VM; Ari, N; Ozçelikay, AT; Oztürk, Y; Ozüari, A; Pekiner, C | 1 |
| Becker, DJ; Henquin, JC; Ongemba, LN | 1 |
| McNeill, JH; Thompson, KH | 1 |
| Dai, S; McNeill, JH; Thompson, KH | 1 |
| Dai, S; McNeill, JH | 1 |
| Leichter, J; McNeill, JH; Thompson, KH | 1 |
| Brownsey, RW; Cam, MC; McNeill, JH; Pederson, RA | 1 |
| Barrera-Hernandez, G; Wanke, IE; Wong, NC | 1 |
| Sakurai, H; Tsuji, A | 1 |
| Bali, JP; Cadène, A; Cros, G; Magous, R; Serrano, JJ; Soulié, ML; Teissèdre, PL | 1 |
| Battell, ML; McNeill, JH; Yao, J | 1 |
| Ahmadi, S; Dehghani, GA; Omrani, GR | 1 |
| Hoshi, K; Ichihara, K; Satoh, K; Tatsuki, R; Tsunajima, T; Yamamoto, A | 1 |
| Cros, G; Deville de Périère, D; Egea, JC; Gross, R; Masiello, P; Poucheret, P; Ribes, G; Serrano, JJ | 1 |
| Amin, SS; Brichard, SM; Buchet, JP; Crans, DC; Ongemba, LN; Reul, BA | 1 |
| Brunetti, IL; Kettelhut, IC; Magnani, MR; Pepato, MT | 1 |
| Cacini, W; Sarangarajan, R | 1 |
| Cheng, JT; Chi, TC; Liu, IM | 1 |
| Crans, DC; Goldfine, AB; Khan, HR; Kostyniak, PJ; McNeill, JH; Willsky, GR; Yang, LQ | 1 |
| Li, H; Wei, Q | 1 |
| Corbella, J; Domingo, JL; Gomez, M; Llobet, JM; Sanchez, DJ | 1 |
| Kawada, J; Nukatsuka, M; Sakurai, H; Sofue, M; Tsuchiya, K | 1 |
| Cros, GH; Diaz, J; McNeill, JH; Mongold, JJ; Ramanadham, S; Serrano, JJ; Siou, G; Tep, A; Vian, L | 1 |
| Brownsey, RW; Cros, GH; McNeill, JH; Mongold, JJ; Ramanadham, S | 2 |
2 review(s) available for vanadyl sulfate and Alloxan Diabetes
| Article | Year |
|---|---|
Vanadium (vanadyl sulfate). Monograph.
Topics: Animals; Clinical Trials as Topic; Diabetes Mellitus; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Humans; Hypoglycemic Agents; Vanadium Compounds | 2009 |
Pharmacokinetic study and trial for preparation of enteric-coated capsule containing insulinomimetic vanadyl compounds: implications for clinical use.
Topics: Administration, Oral; Animals; Capsules; Diabetes Mellitus, Experimental; Electron Spin Resonance Spectroscopy; Gelatin; Hypoglycemic Agents; Molecular Structure; Organometallic Compounds; Picolinic Acids; Rats; Rats, Wistar; Vanadates; Vanadium Compounds | 2004 |
1 trial(s) available for vanadyl sulfate and Alloxan Diabetes
| Article | Year |
|---|---|
Effect of vanadium(IV) compounds in the treatment of diabetes: in vivo and in vitro studies with vanadyl sulfate and bis(maltolato)oxovandium(IV).
Topics: Animals; Apoproteins; Biological Availability; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Electron Spin Resonance Spectroscopy; Fasting; Humans; Hypoglycemic Agents; Immunoglobulin G; Male; Pyrones; Rats; Rats, Wistar; Serum Albumin; Streptozocin; Transferrin; Treatment Outcome; Vanadates; Vanadium; Vanadium Compounds | 2001 |
54 other study(ies) available for vanadyl sulfate and Alloxan Diabetes
| Article | Year |
|---|---|
Galaxaura elongata Extract (GE) Modulates Vanadyl Sulfate-Induced Renal Damage via Regulating TGF-β/Smads and Nrf2/NF-κB Pathways.
Topics: Animals; Antioxidants; Diabetes Mellitus, Experimental; Kidney; Male; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; Rats; Rats, Wistar; Rhodophyta; RNA, Messenger; Transforming Growth Factor beta; Vanadium Compounds | 2022 |
Hepatotoxicity of vanadyl sulfate in nondiabetic and streptozotocin-induced diabetic rats.
Topics: Animals; Blood Glucose; Body Weight; Chemical and Drug Induced Liver Injury; Diabetes Mellitus, Experimental; Humans; Hypoglycemic Agents; Liver; Liver Function Tests; Male; Oxidative Stress; Rats; Rats, Wistar; Streptozocin; Treatment Outcome; Vanadium Compounds | 2018 |
Protective effect of vanadyl sulfate on skin injury in streptozotocin-induced diabetic rats.
Topics: Animals; Blood Glucose; Catalase; Diabetes Mellitus, Experimental; Glutathione; Glutathione Transferase; Glycosylation; Hypoglycemic Agents; Male; Protective Agents; Rats; Skin; Vanadium Compounds | 2013 |
Ameliorative effect of vanadium on oxidative stress in stomach tissue of diabetic rats.
Topics: Administration, Oral; Animals; Diabetes Mellitus, Experimental; Hypoglycemic Agents; Male; Oxidative Stress; Oxidoreductases; Rats; Stomach; Vanadium Compounds | 2014 |
Vanadyl sulfate treatment stimulates proliferation and regeneration of beta cells in pancreatic islets.
Topics: Animals; Biomarkers; Blood Glucose; Cell Proliferation; Diabetes Mellitus, Experimental; Hypoglycemic Agents; Insulin; Insulin-Secreting Cells; Male; Rats, Wistar; Regeneration; Streptozocin; Time Factors; Vanadium Compounds | 2014 |
Synthesis, characterization, and efficacy evaluation of a new anti-diabetic vanadyl(II) thiamine hydrochloride complex in streptozotocin-induced diabetic rats.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Hypoglycemic Agents; Insulin; Liver; Male; Rats; Rats, Wistar; Streptozocin; Thiamine; Vanadium Compounds | 2015 |
Effects of oral vanadium on glycaemic and lipid profile in rats.
Topics: Administration, Oral; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Hypoglycemic Agents; Insulin; Lipids; Random Allocation; Rats; Rats, Sprague-Dawley; Vanadium; Vanadium Compounds | 2016 |
Identification of a new anti-diabetic agent by combining VOSO4 and vitamin E in a single molecule: studies on its spectral, thermal and pharmacological properties.
Topics: Animals; Blood Glucose; Calorimetry; Creatinine; Diabetes Mellitus, Experimental; Hemoglobins; Hypoglycemic Agents; Insulin Resistance; Microscopy, Electron, Scanning; Rats; Solubility; Spectrum Analysis; Temperature; Thermodynamics; Thermogravimetry; Vanadium Compounds; Vitamin E; Water; X-Ray Diffraction | 2010 |
Pancreatic islet beta cell protective effect of oral vanadyl sulphate in streptozotocin-induced diabetic rats, an ultrastructure study.
Topics: Animals; Diabetes Mellitus, Experimental; Islets of Langerhans; Male; Rats; Rats, Wistar; Streptozocin; Vanadium Compounds | 2010 |
Influence of vanadium supplementation on oxidative stress factors in the muscle of STZ-diabetic rats.
Topics: Animals; Antioxidants; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Dietary Supplements; Male; Muscle, Skeletal; Oxidative Stress; Rats; Streptozocin; Vanadium Compounds | 2011 |
Preparation and characterization of vanadyl complexes with bidentate maltol-type ligands; in vivo comparisons of anti-diabetic therapeutic potential.
Topics: Administration, Oral; Animals; Blood Glucose; Carbon Radioisotopes; Diabetes Mellitus, Experimental; Female; Half-Life; Hypoglycemic Agents; Injections, Intraperitoneal; Ligands; Models, Molecular; Organometallic Compounds; Rats; Rats, Sprague-Dawley; Vanadium; Vanadium Compounds | 2003 |
Effects of vanadyl sulfate on kidney in experimental diabetes.
Topics: Animals; Blood Glucose; Creatinine; Diabetes Mellitus, Experimental; Fructose; Glutathione; Glycosylation; Hypoglycemic Agents; Kidney; Male; Microscopy, Electron; Rats; Urea; Vanadium Compounds | 2003 |
Influence of vanadyl sulphate [VOSO4] on biochemical activity and morphology of control and streptozotocin-diabetic rat liver Golgi complexes.
Topics: Animals; Diabetes Mellitus, Experimental; Female; Golgi Apparatus; Liver; Microscopy, Electron; Rats; Rats, Wistar; Vanadium Compounds | 2004 |
Improvement of diabetic states in streptozotocin-induced type 1 diabetic rats by vanadyl sulfate in enteric-coated capsules.
Topics: Administration, Oral; Animals; Biological Availability; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Glucose Tolerance Test; Hypoglycemic Agents; Male; Rats; Rats, Wistar; Streptozocin; Tablets, Enteric-Coated; Vanadium Compounds | 2005 |
Effects of vanadyl sulfate on liver of streptozotocin-induced diabetic rats.
Topics: Alkaline Phosphatase; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Glutathione; Glycosylation; Hypoglycemic Agents; Lipid Peroxidation; Liver; Male; Microscopy, Electron; Rats; Transaminases; Vanadium Compounds | 2005 |
Effects of STZ-induced diabetes and its treatment with vanadyl sulphate on cyclosporine A-induced nephrotoxicity in rats.
Topics: Animals; Cyclosporine; Diabetes Mellitus, Experimental; Glutathione; Hypoglycemic Agents; Immunosuppressive Agents; Kidney; Kidney Diseases; Kidney Function Tests; Male; Malondialdehyde; Organ Size; Rats; Rats, Wistar; Vanadium Compounds | 2005 |
Effect of insulin-mimetic vanadyl sulfate on cytochrome P450 2E1-dependent p-nitrophenol hydroxylation in the liver microsomes of streptozotocin-induced type 1 diabetic rats.
Topics: Age Factors; Analysis of Variance; Animals; Cytochrome P-450 CYP2E1; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Electron Spin Resonance Spectroscopy; Hydroxylation; Hypoglycemic Agents; Immunoblotting; Microsomes, Liver; Nitrophenols; Rats; Rats, Wistar; Spin Trapping; Streptozocin; Vanadium Compounds | 2005 |
Effect of bis[curcumino]oxovanadium complex on non-diabetic and streptozotocin-induced diabetic rats.
Topics: Animals; Blood Glucose; Blood Pressure; Curcumin; Diabetes Mellitus, Experimental; Hypoglycemic Agents; Hypolipidemic Agents; Lipids; Male; Organometallic Compounds; Rats; Rats, Wistar; Vanadium Compounds | 2005 |
The effects of peroxovanadate and peroxovanadyl on glucose metabolism in vivo and identification of signal transduction proteins involved in the mechanism of action in isolated soleus muscle.
Topics: Animals; Diabetes Mellitus, Experimental; Glucose; Glycogen; Hyperglycemia; Hypoglycemic Agents; Insulin; Lactic Acid; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Muscle, Skeletal; Phosphorylation; Rats; Rats, Wistar; Signal Transduction; Vanadates; Vanadium Compounds | 2005 |
Protective effect of vanadyl sulfate on the pancreas of streptozotocin-induced diabetic rats.
Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Hypoglycemic Agents; Male; Pancreas; Rats; Vanadium Compounds | 2005 |
Effect of vanadyl sulfate on the status of lipid parameters and on stomach and spleen tissues of streptozotocin-induced diabetic rats.
Topics: Administration, Oral; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Gastric Mucosa; Glutathione; Hypoglycemic Agents; Lipid Peroxidation; Lipids; Male; Oxidative Stress; Rats; Spleen; Stomach; Streptozocin; Vanadium Compounds | 2006 |
Vanadyl sulfate administration protects the streptozotocin-induced oxidative damage to brain tissue in rats.
Topics: Administration, Oral; Animals; Body Weight; Brain; Catalase; Diabetes Mellitus, Experimental; Glutathione; Glycosylation; Hypoglycemic Agents; L-Lactate Dehydrogenase; Lipid Peroxidation; Male; N-Acetylneuraminic Acid; Oxidative Stress; Rats; Streptozocin; Uric Acid; Vanadium Compounds | 2006 |
Diabetes-altered gene expression in rat skeletal muscle corrected by oral administration of vanadyl sulfate.
Topics: Administration, Oral; Analysis of Variance; Animals; Blood Glucose; Cholesterol; Diabetes Mellitus, Experimental; Fatty Acids, Nonesterified; Gene Expression; Hyperglycemia; Hypoglycemic Agents; Lipid Metabolism; Male; Muscle, Skeletal; Oligonucleotide Array Sequence Analysis; Oxidative Stress; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Triglycerides; Vanadium Compounds | 2006 |
Reduction of oxidative stress induced vanadium toxicity by complexing with a flavonoid, quercetin: a pragmatic therapeutic approach for diabetes.
Topics: Animals; Antioxidants; CHO Cells; Cricetinae; Cricetulus; Diabetes Mellitus, Experimental; Hypoglycemic Agents; Kidney; Mice; Mice, Inbred BALB C; Organometallic Compounds; Oxidative Stress; Quercetin; Toxicity Tests, Acute; Vanadium Compounds | 2006 |
Vanadyl sulfate, taurine, and combined vanadyl sulfate and taurine treatments in diabetic rats: effects on the oxidative and antioxidative systems.
Topics: Animals; Antioxidants; Blood Glucose; Diabetes Mellitus, Experimental; Hypoglycemic Agents; Liver; Male; Malondialdehyde; Muscle, Skeletal; Myocardium; Oxidants; Oxidation-Reduction; Oxidative Stress; Rats; Rats, Wistar; Taurine; Vanadium Compounds | 2007 |
Enzymatic activities in brains of diabetic rats treated with vanadyl sulphate and sodium tungstate.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Brain; Creatine Kinase; Diabetes Mellitus, Experimental; Energy Metabolism; Enzyme Activation; Hypoglycemic Agents; Male; Rats; Rats, Wistar; Tungsten Compounds; Vanadium Compounds | 2007 |
Mechanism on insulin-like action of vanadyl sulfate: studies on interaction between rat adipocytes and vanadium compounds.
Topics: Adipocytes; Animals; Blood Glucose; Cytochrome b Group; Diabetes Mellitus, Experimental; Electron Spin Resonance Spectroscopy; Fatty Acids, Nonesterified; Glucose; Hypoglycemic Agents; In Vitro Techniques; Insulin; Male; Monosaccharide Transport Proteins; Rats; Rats, Wistar; Subcellular Fractions; Tissue Distribution; Vanadium Compounds | 1995 |
Skeletal muscle mitogen-activated protein kinases and ribosomal S6 kinases. Suppression in chronic diabetic rats and reversal by vanadium.
Topics: Animals; Calcium-Calmodulin-Dependent Protein Kinases; Chromatography, Ion Exchange; Diabetes Mellitus, Experimental; Hypoglycemic Agents; Insulin; Insulin Resistance; Kinetics; Muscle, Skeletal; Protein Serine-Threonine Kinases; Pyrones; Rats; Rats, Wistar; Reference Values; Ribosomal Protein S6 Kinases; Ribosomes; Time Factors; Vanadates; Vanadium; Vanadium Compounds | 1995 |
Comparison of the glucose-lowering properties of vanadyl sulfate and bis(maltolato)oxovanadium(IV) following acute and chronic administration.
Topics: Administration, Oral; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Hypoglycemic Agents; Injections, Intraperitoneal; Injections, Intravenous; Male; Pyrones; Rats; Rats, Wistar; Time Factors; Vanadates; Vanadium Compounds | 1995 |
Toxicity studies on one-year treatment of non-diabetic and streptozotocin-diabetic rats with vanadyl sulphate.
Topics: Administration, Oral; Alanine Transaminase; Animals; Aspartate Aminotransferases; Body Weight; Diabetes Mellitus, Experimental; Male; Organ Size; Rats; Rats, Wistar; Streptozocin; Tissue Distribution; Urea; Urinary Calculi; Vanadium Compounds | 1994 |
The effect of vanadyl treatment on vascular responsiveness of streptozotocin-diabetic rats.
Topics: Administration, Oral; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Insulin; Male; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Potassium Chloride; Random Allocation; Rats; Streptozocin; Vanadium Compounds | 1994 |
Comparison of the effects of various vanadium salts on glucose homeostasis in streptozotocin-diabetic rats.
Topics: Analysis of Variance; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Disease Models, Animal; Glycosuria; Homeostasis; Insulin; Male; Rats; Rats, Wistar; Streptozocin; Vanadates; Vanadium Compounds | 1994 |
Effect of vanadyl sulfate feeding on susceptibility to peroxidative change in diabetic rats.
Topics: Administration, Oral; Animals; Cataract; Diabetes Mellitus, Experimental; Glutamate-Ammonia Ligase; Glutathione; Lipid Peroxidation; Liver; Male; Rats; Rats, Wistar; Streptozocin; Thiobarbituric Acid Reactive Substances; Vanadium; Vanadium Compounds | 1993 |
One-year treatment of streptozotocin-induced diabetic rats with vanadyl sulphate.
Topics: Administration, Oral; Animals; Blood Glucose; Body Weight; Cataract; Diabetes Mellitus, Experimental; Drinking; Eating; Hypoglycemic Agents; Insulin; Lipids; Male; Rats; Rats, Wistar; Time Factors; Vanadium Compounds | 1994 |
One-year treatment of non-diabetic and streptozotocin-diabetic rats with vanadyl sulphate did not alter blood pressure or haematological indices.
Topics: Administration, Oral; Animals; Blood Cell Count; Blood Pressure; Diabetes Mellitus, Experimental; Hemodynamics; Hemoglobins; Hypoglycemic Agents; Male; Rats; Rats, Wistar; Time Factors; Vanadium Compounds | 1994 |
Studies of vanadyl sulfate as a glucose-lowering agent in STZ-diabetic rats.
Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Energy Intake; Glutathione Reductase; Hypoglycemic Agents; Kidney; Male; Rats; Rats, Wistar; Vanadium; Vanadium Compounds | 1993 |
Long-term effectiveness of oral vanadyl sulphate in streptozotocin-diabetic rats.
Topics: Adipose Tissue; Administration, Oral; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Drinking Behavior; Feeding Behavior; Gastric Inhibitory Polypeptide; Glucose; Glucose Tolerance Test; Glycerol; Hypoglycemic Agents; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Kidney; Liver; Male; Rats; Rats, Wistar; Vanadium; Vanadium Compounds | 1993 |
Phlorizin or vanadate treatment reverses impaired expression of albumin and hepatocyte nuclear factor 1 in diabetic rats.
Topics: Animals; Base Sequence; Binding Sites; Blood Glucose; Diabetes Mellitus, Experimental; DNA-Binding Proteins; Hepatocyte Nuclear Factor 1; Hepatocyte Nuclear Factor 1-alpha; Hepatocyte Nuclear Factor 1-beta; Liver; Male; Molecular Sequence Data; Nuclear Proteins; Oligodeoxyribonucleotides; Phlorhizin; Promoter Regions, Genetic; Rats; Rats, Sprague-Dawley; Reference Values; RNA, Messenger; Serum Albumin; Suppression, Genetic; Transcription Factors; Transcription, Genetic; Vanadates; Vanadium Compounds | 1996 |
Vanadyl ion suppresses nitric oxide production from peritoneal macrophages of streptozotocin-induced diabetic mice.
Topics: Animals; Diabetes Mellitus, Experimental; Hypoglycemic Agents; Insulin; Macrophages, Peritoneal; Male; Mice; Mice, Inbred BALB C; Nitric Oxide; Streptozocin; Vanadium Compounds | 1996 |
Contractile effects of nanomolar concentrations of vanadyl sulphate on gastric smooth muscle cells isolated from normal or diabetic rats.
Topics: Animals; Diabetes Mellitus, Experimental; Hypoglycemic Agents; In Vitro Techniques; Muscle Contraction; Muscle, Smooth; Rats; Stomach; Vanadium Compounds | 1996 |
Acute and chronic response to vanadium following two methods of streptozotocin-diabetes induction.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Fatty Acids, Nonesterified; Glucose Tolerance Test; Hypoglycemic Agents; Insulin; Pyrones; Rats; Rats, Sprague-Dawley; Rats, Wistar; Streptozocin; Triglycerides; Vanadates; Vanadium Compounds | 1997 |
Effects of vanadyl sulphate on glucose homeostasis in severe diabetes induced by streptozotocin in rats.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Drinking; Homeostasis; Hypoglycemic Agents; Insulin; Male; Rats; Streptozocin; Vanadium Compounds; Weight Loss | 1997 |
Improvement of impaired glucose tolerance by oral administration of vanadyl sulfate by gavage in streptozotocin-induced diabetic rats.
Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Glucose Tolerance Test; Hypoglycemic Agents; Insulin; Intubation, Gastrointestinal; Male; Rats; Rats, Sprague-Dawley; Vanadium Compounds | 1997 |
Vanadyl treatment normalizes submandibular salivary gland insulin-like immunoreactivity in streptozotocin-diabetic rats.
Topics: Animals; Diabetes Mellitus, Experimental; Hypoglycemic Agents; Insulin; Male; Rats; Rats, Wistar; Submandibular Gland; Vanadium Compounds | 1998 |
Effects of vanadium complexes with organic ligands on glucose metabolism: a comparison study in diabetic rats.
Topics: Administration, Oral; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Disinfectants; Glucokinase; Glucose; Hydroxybutyrates; Hypoglycemic Agents; Injections, Intraperitoneal; Insulin; Islets of Langerhans; Ligands; Liver; Liver Glycogen; Male; Muscles; Organometallic Compounds; Pentanones; Phosphoenolpyruvate Carboxykinase (GTP); Pyrones; Pyruvate Kinase; Rats; Rats, Wistar; RNA, Messenger; Time Factors; Vanadates; Vanadium Compounds | 1999 |
Effect of oral vanadyl sulfate treatment on serum enzymes and lipids of streptozotocin-diabetic young rats.
Topics: Administration, Oral; Alanine Transaminase; Animals; Aspartate Aminotransferases; Creatine Kinase; Diabetes Mellitus, Experimental; L-Lactate Dehydrogenase; Lipids; Male; Rats; Rats, Wistar; Streptozocin; Vanadium Compounds | 1999 |
Normalization of hyperglycaemia by oral vanadyl sulfate does not reverse diabetes-induced protection against cisplatin nephrotoxicity in streptozotocin-diabetic rats.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Blood Glucose; Body Weight; Cisplatin; Diabetes Mellitus, Experimental; Drug Interactions; Glycated Hemoglobin; Hyperglycemia; Hypoglycemic Agents; Kidney Diseases; Male; Organ Size; Rats; Rats, Sprague-Dawley; Vanadium Compounds | 1999 |
Decrease of hypothalamic neuropeptide Y gene expression by vanadyl sulfate in streptozotocin-induced diabetic rats.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Drinking; Eating; Gene Expression; Hypothalamus; Male; Neuropeptide Y; Rats; Rats, Wistar; RNA, Messenger; Vanadium Compounds | 2001 |
Conformation changes in brain calcineurin in diabetic rats with or without treatment with vanadyl sulfate.
Topics: Administration, Oral; Animals; Blood Glucose; Brain; Calcineurin; Diabetes Mellitus, Experimental; Electron Spin Resonance Spectroscopy; Hypoglycemic Agents; Male; Protein Conformation; Rats; Rats, Wistar; Vanadium Compounds | 2001 |
Administration of vanadyl sulfate by gavage does not normalize blood glucose levels in streptozotocin-induced diabetic rats.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Drug Administration Routes; Male; Rats; Rats, Inbred Strains; Stomach; Tissue Distribution; Vanadium; Vanadium Compounds | 1992 |
Insulin-like effect of vanadyl ion on streptozotocin-induced diabetic rats.
Topics: Adipose Tissue; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Electron Spin Resonance Spectroscopy; Glucose; Insulin; Male; Rats; Rats, Inbred Strains; Vanadium; Vanadium Compounds | 1990 |
Toxicological aspects of vanadyl sulphate on diabetic rats: effects on vanadium levels and pancreatic B-cell morphology.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Islets of Langerhans; Male; Rats; Rats, Inbred Strains; Vanadium; Vanadium Compounds | 1990 |
Oral vanadyl sulfate in treatment of diabetes mellitus in rats.
Topics: Administration, Oral; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Drinking; Glycerol; Heart; Insulin; Male; Phosphorylation; Proteins; Rats; Rats, Inbred Strains; Vanadium; Vanadium Compounds | 1989 |
Sustained prevention of myocardial and metabolic abnormalities in diabetic rats following withdrawal from oral vanadyl treatment.
Topics: Adipose Tissue; Animals; Blood Glucose; Body Weight; Culture Techniques; Diabetes Mellitus, Experimental; Glycerol; Heart; Insulin; Lipid Metabolism; Male; Organ Size; Rats; Rats, Inbred Strains; Thyroid Hormones; Vanadium; Vanadium Compounds | 1989 |